Skip to main content
. 2023 Jun 26;8(9):1801–1810. doi: 10.1016/j.ekir.2023.06.018

Table 3.

Kidney disease-related characteristics of patients at the index date

Variables All patients
N = 769
RP
N = 426
SP
N = 342
P value
Serum creatinine (mg/dl) 1.12 ± 0.40 1.18 ± 0.40 1.04 ± 0.38 <0.01
eGFR (ml/min per 1.73 m2) 68.3 ± 28.4 64.6 ± 27.5 72.9 ± 29.0 <0.01
Blood urea nitrogen (mg/dl) 18.9±14.3 19.7±17.4 17.6±7.6 0.08
Uric acid (mg/dl) 5.7±1.6 5.9±1.5 5.4±1.6 <0.01
Urine PCR (mg/mg) 160.6 ± 310.9 188.9 ± 341.6 114.3± 305.4 0.01
CKD stage (%) <0.01
1 229 (29.8) 107 (25.1) 122 (35.7)
2 259 (33.7) 141 (33.1) 118 (34.5)
3a 134 (17.5) 77 (18.1) 57 (16.7)
3b 146 (19.0) 101 (23.7) 45 (13.2)
Mayo imaging classification N = 394 N = 285 N = 109 <0.01
 Class 1A 26(6.6) 3(1.1) 23(21.1)
 Class 1B 101(25.6) 15(5.3) 86(78.9)
 Class 1C 149(37.8) 149(52.3) 0(0.0)
 Class 1D 8(20.8) 82(28.8) 0(0.0)
 Class 1E 36(9.1) 36(12.6) 0(0.0)
HtTKV(ml/m) 1002.8 ± 664.8 1211.6 ± 667.4 473.3 ± 207.6 <0.01
Kidney length by ultrasound (cm) 13.5 ± 3.1 (N = 50) 15.3 ± 3.0 (N = 17) 12.6 ± 2.7 (N = 33) <0.01
Genetic test results N = 256 N = 181 N = 75
PKD1 PT mutation 118(46.1) 95(52.5) 23(30.7) <0.01
PKD1 NT mutation 66(25.8) 45(24.9) 21(28.0) 0.03
 PKD2 mutation 48(18.8) 29(16.0) 19(25.3) 0.48
Mutation not found 24(9.4) 12(6.6) 12(16.0) 0.58
Unknown 612(66.7) 245(63.6) 267(78.1) <0.01
PROPKD score N = 181 N = 135 N = 46 <0.01
0–3 64 (35.4) 38(28.1) 26(56.5)
4–6 70(38.7) 50(37.0) 20(43.5)
7–9 47(26.0) 47(34.8) 0(0)
Missing 587(76.4) 292(68.5) 292(86.3) <0.01

CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; htTKV, height-adjusted total kidney volume; PCR, protein-to-creatinine ratio; PKD1 NT, PKD1 nontruncating; PKD1 PT, PKD1 protein truncating; RP, rapid progressor; SP, slow progressor.